Список литературы

Бельцевич Д.Г., Кузнецов Н.С., Солтдатова Т.В. В.В.Э. Инциденталома надпочечников. // Эндокринная хирургия. 2009. № 4(1). С. 19–23.

Fassnacht M., Arlt W., Bancos I., Dralle H., Newell-Price J., Sahdev A., Tabarin A., Terzolo M., Tsagarakis S., Dekkers O.M. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors // European Journal of Endocrinology. 2016. № 2(175). С. 1–34. DOI:10.1530/EJE-16-0467.

Mansmann G., Lau J., Balk E., Rothberg M., Miyachi Y., Bornstein S.R. The clinically inapparent adrenal mass: Update in diagnosis and management // Endocrine Reviews. 2004. № 2(25). С. 309–340. DOI:10.1210/er.2002-0031.

Berruti A., Baudin E., Gelderblom H., Haak H.R., Porpiglia F., Fassnacht M., Pentheroudakis G. Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up // Annals of Oncology. 2012. № 7(23). С. 131–138. DOI:10.1093/annonc/mds231.

Clark O.H., Ajani J.A., Benson A.B., Berlin J.D., Blaszkowsky L.S., Byrd D., Choti M.A., Doherty G.M., Engstrom P.F., Gibbs J.F., Heslin M.J., Kandeel F., Kessinger A., Kulke M.H., Kunz P., Kvols L., Olson J.A., Ratliff T.W., Salem R., Saltz L., Schteingart D.E., Shah M.H., Shibata S. Neuroendocrine tumors // JNCCN Journal of the National Comprehensive Cancer Network. 2009. № 7(7). С. 712–747. DOI:10.6004/jnccn.2009.0050.

Kloos R.T., Gross M.D., Francis I.R., Korobkin M., Shapiro B. Incidentally discovered adrenal masses // Endocrine Reviews. 1995. № 4(16). С. 460–484. DOI:10.1210/edrv-16- 4-460.

Bovio S., Cataldi A., Reimondo G., Sperone P., Novello S., Berruti A., Borasio P., Fava C., Dogliotti L., Scagliotti G. V., Angeli A., Terzolo M. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series // Journal of Endocrinological Investigation. 2006. № 4(29). С. 298–302. DOI:10.1007/BF03344099.

Young W.F. The Incidentally Discovered Adrenal Mass // New England Journal of Medicine. 2007. № 6(356). С. 601–610. DOI:10.1056/nejmcp065470.

Cawood T.J., Hunt P.J., O’Shea D., Cole D., Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? // European Journal of Endocrinology. 2009. № 4(161). С. 513–527. DOI:10.1530/EJE-09-0234.

Fassnacht M., Dekkers O.M., Else T., Baudin E., Berruti A., De Krijger R.R., Haak H.R., Mihai R., Assie G., Terzolo M. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the study of adrenal tumors // European Journal of Endocrinology. 2018. С. 1–88. DOI:10.1530/EJE-18-0608.

Ahmed A.A., Thomas A.J., Ganeshan D.M., Blair K.J., Lall C., Lee J.T., Morshid A.I., Habra M.A., Elsayes K.M. Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management // Abdominal Radiology. 2020. С. 1–19. DOI:10.1007/s00261-019-02371-y.

Gross M.D., Shapiro B. Clinical review 50: Clinically silent adrenal masses // Journal of Clinical Endocrinology and Metabolism. 1993. № 4(77). С. 885–888. DOI:10.1210/jcem.77.4.8408461.

Terzolo M., Stigliano A., Chiodini I., Loli P., Furlani L., Arnaldi G., Reimondo G., Pia A., Toscano V., Zini M., Borretta G., Papini E., Garofalo P., Allolio B., Dupas B., Mantero F., Tabarin A. AME position statement on adrenal incidentaloma // European Journal of Endocrinology. 2011. № 6(164). С. 851–870. DOI:10.1530/EJE-10-1147.

Terzolo M., Bovio S., Reimondo G., Pia A., Osella G., Borretta G., Angeli A. Subclinical Cushing’s syndrome in adrenal incidentalomas // Endocrinology and Metabolism Clinics of North America. 2005. № 2(34). С. 432–439. DOI:10.1016/j.ecl.2005.01.008.

Terzolo M., Bovio S., Pia A., Conton P.A., Reimondo G., Dall’Asta C., Bemporad D., Angeli A., Opocher G., Mannelli M., Ambrosi B., Mantero F. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma // European Journal of Endocrinology. 2005. № 2(153). С. 307–315. DOI:10.1530/eje.1.01959.

Tauchmanovà L., Rossi R., Biondi B., Pulcrano M., Nuzzo V., Palmieri E.A., Fazio S., Lombardi G. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk // Journal of Clinical Endocrinology and Metabolism. 2002. № 11(87). С. 4872–4878. DOI:10.1210/jc.2001-011766.

Morelli V., Masserini B., Salcuni A.S., Eller-Vainicher C., Savoca C., Viti R., Coletti F., Guglielmi G., Battista C., Iorio L., Beck-Peccoz P., Ambrosi B., Arosio M., Scillitani A., Chiodini I. Subclinical hypercortisolism: Correlation between biochemical diagnostic criteria and clinical aspects // Clinical Endocrinology. 2010. (73). С. 161–166. DOI:10.1111/j.1365-2265.2010.03794.x.

Mantero F., Terzolo M., Arnaldi G., Osella G., Masini A.M., Alì A., Giovagnetti M., Opocher G., Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. // The Journal of clinical endocrinology and metabolism. 2000. № 2(85). С. 637–644. DOI:10.1210/jcem.85.2.6372.

Kirkby-Bott J., Brunaud L., Mathonet M., Hamoir E., Kraimps J.L., Trésallet C., Amar L., Rault A., Henry J.F., Carnaille B. Ectopic hormone-secreting pheochromocytoma: A francophone observational study // World Journal of Surgery. 2012. № 6(36). С. 13820– 1388. DOI:10.1007/s00268-012-1488-1.

Мельниченко Г.А., Алексеев Б.Я., Бельцевич Д.Г., Стилиди И. С., Гордунова В.А., Кузнецов Н.С., Бохян В. Ю. К.А.А. Клинический рекомендации. Рак коры надпочечников (адренокортикальный рак).2020.

Nieman L.K., Biller B.M.K., Findling J.W., Murad M.H., Newell-Price J., Savage M.O., Tabarin A. Treatment of cushing’s syndrome: An endocrine society clinical practice guideline // Journal of Clinical Endocrinology and Metabolism. 2015. № 8(100). С. 2807– 2831. DOI:10.1210/jc.2015-1818.

Libè R., Dall’Asta C., Barbetta L., Baccarelli A., Beck-Peccoz P., Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas // European Journal of Endocrinology. 2002. № 4(147). С. 489–494. DOI:10.1530/eje.0.1470489.

Elhassan Y.S., Alahdab F., Prete A., Delivanis D.A., Khanna A., Prokop L., Murad M.H., O’Reilly M.W., Arlt W., Bancos I. Natural History of Adrenal Incidentalomas with and without Mild Autonomous Cortisol Excess A Systematic Review and Meta-analysis // Annals of Internal Medicine. 2019. № 2(171). С. 107–116. DOI:10.7326/M18-3630.

Кузнецов Н.С., Бельцевич Д.Г., Ванушко В.Э., Солдатова Т.В., Ремизов О.В., Кац Л.Е. Л.М.А. Дифференциальная Диагностика Инциденталом Надпочечников // Эндокринная хирургия. 2016. № 4(13). С. 5–16.

Nieman L.K., Biller B.M.K., Findling J.W., Newell-Price J., Savage M.O., Stewart P.M., Montori V.M., Edwards H. The diagnosis of Cushing’s syndrome: An endocrine society clinical practice guideline // Journal of Clinical Endocrinology and Metabolism. 2008. № 5(93). С. 1526–1540. DOI:10.1210/jc.2008-0125.

Ceccato F., Antonelli G., Frigo A.C., Regazzo D., Plebani M., Boscaro M., Scaroni C. First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS // Journal of Endocrinological Investigation. 2017. № 7(40). С. 753–760. DOI:10.1007/s40618-017-0644-8.

Penezić Z., Zarković M., Vujović S., Beleslin B., Cirić J., Drezgić M. Value of assessing adrenocorticotropic hormone (ACTH) levels in differential diagnosis of hypercorticism. // Medicinski pregled. 2004. № 7(57). С. 335–342. DOI:10.2298/MPNS0408335P.

Olsen H., Kjellbom A., Löndahl M., Lindgren O. Suppressed ACTH Is Frequently Unrelated to Autonomous Cortisol Secretion in Patients with Adrenal Incidentalomas // Journal of Clinical Endocrinology and Metabolism. 2018. № 2(104). С. 506–512. DOI:10.1210/jc.2018-01029.

Di Dalmazi G., Berr C.M., Fassnacht M., Beuschlein F., Reincke M. Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: A systematic review of the literature // Journal of Clinical Endocrinology and Metabolism. 2014. № 8(99). С. 2637–2645. DOI:10.1210/jc.2014-1401.

Prete A., Paragliola R.M., Bottiglieri F., Rota C.A., Pontecorvi A., Salvatori R., Corsello S.M. Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome // Endocrine. 2017. № 3(55). С. 969–980. DOI:10.1007/s12020-016-1007-5.

Hurtado M.D., Cortes T., Natt N., Young W.F., Bancos I. Extensive clinical experience: Hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin- independent cortisol excess // Clinical Endocrinology. 2018. № 6(89). С. 721–733. DOI:10.1111/cen.13803.

Schalin-Jäntti C., Raade M., Hämäläinen E., Sane T. A 5-year prospective follow-up study of lipid-rich adrenal incidentalomas: No tumor growth or development of hormonal hypersecretion // Endocrinology and Metabolism. 2015. № 4(30). С. 481–487. DOI:10.3803/EnM.2015.30.4.481.

Lenders J.W.M., Duh Q.Y., Eisenhofer G., Gimenez-Roqueplo A.P., Grebe S.K.G., Murad M.H., Naruse M., Pacak K., Young W.F. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline // Journal of Clinical Endocrinology and Metabolism. 2014. № 6(99). С. 1915–1942. DOI:10.1210/jc.2014-1498.

Därr R., Kuhn M., Bode C., Bornstein S.R., Pacak K., Lenders J.W.M., Eisenhofer G. Accuracy of recommended sampling and assay methods for the determination of plasma- free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review // Endocrine. 2017. № 3(56). С. 495–503. DOI:10.1007/s12020-017-1300-y.

Mullins F., O’Shea P., FitzGerald R., Tormey W. Enzyme-linked immunoassay for plasma-free metanephrines in the biochemical diagnosis of phaeochromocytoma in adults is not ideal // Clinical Chemistry and Laboratory Medicine. 2012. № 1(50). С. 105–110. DOI:10.1515/CCLM.2011.742.

Мельниченко Г.А., Трошина Е.А., Бельцевич Д.Г. Ю.М.Ю. Феохромоцитома / параганглиома.2016. С. 1–34. DOI:10.14341/serg2015315-33.

Lenders J.W.M., Pacak K., Walther M.M., Marston Linehan W., Mannelli M., Friberg P., Keiser H.R., Goldstein D.S., Eisenhofer G. Biochemical diagnosis of pheochromocytoma: Which test is best? // Journal of the American Medical Association. 2002. № 11(287). С. 1427–1434. DOI:10.1001/jama.287.11.1427.

Sbardella E., Grossman A.B. Pheochromocytoma: An approach to diagnosis // Best Practice and Research: Clinical Endocrinology and Metabolism. 2020. № 2(34). С. 1–25. DOI:10.1016/j.beem.2019.101346.

Yu R., Wei M. False positive test results for pheochromocytoma from 2000 to 2008 // Experimental and Clinical Endocrinology and Diabetes. 2010. № 9(118). С. 577–585. DOI:10.1055/s-0029-1237699.

Neary N.M., King K.S., Pacak K. Drugs and Pheochromocytoma — Don’t Be Fooled by Every Elevated Metanephrine // New England Journal of Medicine. 2011. № 364. С. 2268–2270. DOI:10.1056/nejmc1101502.

Eisenhofer G., Goldstein D.S., Walther M.M., Friberg P., Lenders J.W.M., Keiser H.R., Pacak K. Biochemical diagnosis of pheochromocytoma: How to distinguish true- from false-positive test results // Journal of Clinical Endocrinology and Metabolism. 2003. № 6(88). С. 2656–2666. DOI:10.1210/jc.2002-030005.

Meyer-Rochow G.Y., Schembri G.P., Benn D.E., Sywak M.S., Delbridge L.W., Robinson B.G., Roach P.J., Sidhu S.B. The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma // Annals of Surgical Oncology. 2010. № 2(17). С. 392– 400. DOI:10.1245/s10434-009-0850-5.